AlphAIAlphAI — Financial news for AI agents
prnewswire.comOCT 11 min read$CAH

Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5

Cardinal Health (CAH) will release its fiscal Q1 2027 results on November 5 before the NYSE opening. A webcast discussion will follow at 8:30 a.m. ET. The company is a distributor of pharmaceuticals and medical products. Details will be available on their Investor Relations page.

Original reporting
prnewswire.com
Published Oct 1, 2026, 10:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 10:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5 — source image
Source · prnewswire.com
Decision brief

The 30-second read

$CAHNeutralMed
01

Why it matters

The announcement sets the calendar for market participants; traders may adjust positions based on expectations of earnings surprise.

02

Market read

The release date announcement is a modestly material corporate event that may generate short‑term trading interest.

03

What to watch

Potential impact of macro‑economic conditions on Cardinal Health's upcoming earnings has not been discussed.

Relevance 5/10Novelty 5/10Timing: pre‑market on Nov 5

Background

Cardinal Health is a major U.S. distributor of pharmaceuticals and medical products. The company typically releases earnings quarterly, and the timing can influence short‑term stock movement.

Company-level read

Ticker impact

$CAHNeutralHigh confidence
Context

Cardinal Health announced it will release its FY2027 Q1 results on November 5, a new disclosure of the earnings release timing.

Expected impact

potential heightened trading activity with unclear direction until results are posted

Evidence & confidence

Earnings release dates are material for traders; no guidance is given, so the impact is limited to timing‑related positioning.

Market effects

Sector

May affect the healthcare distribution sector as peers watch Cardinal Health's results for market trends.

Regional

U.S. investors will note the release; limited broader regional effect.

Global

Low global relevance beyond U.S. healthcare investors.

Counterpoint

What could challenge this read

Without guidance, the stock could be oversold ahead of the release, presenting a buying opportunity if market overreacts to the announcement.

Key entities

  • Company
    Cardinal Health

    U.S. healthcare distribution and services firm (NYSE: CAH).

Read at source← All news

Related articles

OCT 3
$CAHMed

How CVS Deal Extension At Cardinal Health (CAH) Has Changed Its Investment Story

Cardinal Health (CAH) extended its pharmaceutical distribution agreement with CVS Health until 2032, reaffirming its fiscal 2027 non-GAAP EPS growth guidance of 13% to 15%. The extension secures a key partner, supporting Cardinal's strategy to shift toward higher-margin services. Analysts expect revenue of $297.6 billion and earnings of $3.0 billion by 2029. The company's upcoming Q1 results on November 5 will provide further insights.

simplywall.st2 min
OCT 1
$CAHHigh

Why is Cardinal Health stock rallying today?

Cardinal Health (CAH) stock rose 3.8% after extending its pharmaceutical distribution agreement with CVS Health (CVS) until 2032, removing investor uncertainty. The company reaffirmed its FY2027 EPS guidance of $12.40-$12.60. Today is the ex-dividend date for its quarterly dividend of $0.516 per share. The stock reached $235.95 intraday, with broader market gains providing a supportive backdrop.

investing.com2 min
OCT 1
$MCKMed

McKesson (MCK) and Cardinal Health Extend CVS Health Distributio

McKesson (MCK) and Cardinal Health renewed their pharmaceutical distribution agreements with CVS Health, extending contracts through June 2032. Both companies reaffirmed their fiscal 2027 earnings guidance. McKesson's stock is trading at $890.28, 6.8% above its GF Value of $833.49, with a GF Score of 86/100. Insider sales totaled $28.3 million over the past year, while 15 premium gurus hold MCK with a net positive addition.

gurufocus.com2 min
OCT 1
$CAHMed

Why Is Cardinal Health and McKesson Stock Trading Higher Today - CVS Health (NYSE:CVS), McKesson (NYSE:MC

Cardinal Health (CAH) and McKesson (MCK) extended their distribution agreements with CVS Health (CVS) until 2032. Cardinal Health reaffirmed its 2027 adjusted earnings guidance of $12.40-$12.60 per share, while McKesson reiterated its 2027 outlook of $44.20-$45 per share. Both companies' stocks rose on the news, with McKesson up 4.28% and Cardinal Health up 2.94%.

benzinga.com2 min